To confirm the clinical relevance of SET protein in NSLCL, we first analyzed the presence of SET in the tumor tissue obtained from 53 patients with NSCLC and the adjacent normal parts of lung in 43 patients of this cohort (Table 1 and Figure 1A). This evidence concerns the gene SET and neoplasm.